Kyntra Bio, Inc. Common Stock (NASDAQ: KYNB) last traded at $7.52, up 2.73% on the session. The quote above updates while this page is open; the figures below are drawn from Kyntra Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
Kyntra Bio, Inc. Common Stock trades on NASDAQ under the ticker KYNB. Its market capitalisation is $30.45 million.
Valuation measures for Kyntra Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $30.45M |
|---|---|
| Enterprise value | $89.03M |
| P/E ratio | 0.17 |
| Price / sales | 6.60 |
| Beta | 1.09 |
Trailing-twelve-month figures tagged in Kyntra Bio, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $4.62M |
|---|---|
| Net income (TTM) | $183.19M |
| EPS (TTM) | $45.30 |
| Operating margin | -1089.78% |
| Cash | $50.64M |
Range and volume for KYNB over the past 52 weeks.
| 52-week high | $12.60 |
|---|---|
| 52-week low | $6.32 |
| Volume | 39.8K |
| Average volume | 19.0K |
| Previous close | $7.32 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.